ABOUT CURIUM

The Group Curium is the world’s largest nuclear medicine company. At Curium, we have a singular focus – to develop, manufacture and supply world-class radiopharmaceutical products around the globe. With manufacturing facilities across Europe, Middle East and the United States, Curium delivers SPECT, PET and therapeutic radiopharmaceutical solutions for life-threatening diseases to over 14 million patients annually. Our proven heritage combined with a pioneering approach are the hallmarks to deliver innovation, excellence, and unparalleled service. As a fast-growing company in a niche market, Curium is today owned by a private equity fund with LBO financing scheme. 

With €1 billion revenues in , Curium International is specialized into the production and marketing of 25+ radiopharmaceuticals products, covering 12 indications (such as oncology, cardiology, neurology pulmonary…). Our network provides optimal coverage across the world in the ...